Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Neuropeptide Therapy of Recent Onset Type 1 Diabetes
- First Posted Date
- 2016-07-01
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- Vanilloid Genetics Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02820558
- Locations
- 🇨🇦
Hospital for Sick Children, Toronto, Ontario, Canada
News
No news found